Patent · US Active

Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof

US9598447B2 · kind B2 · utility

1Cited by

31References

60Claims

0Family size

Assignee

PURDUE PHARMA L.P. · US

Inventors

Dawit Tadesse · Avenel, US
Laykea Tafesse · Robinsville, US
Xiaoming Zhou · Plainsboro, US

Key dates

Filing date	Dec 21, 2011
Grant date	Mar 21, 2017
Priority date	—
Expiry date	Sep 20, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/65583
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to Phosphorus-Substituted Quinoxaline-Type Piperidine Compounds of Formula (I):and pharmaceutically acceptable derivatives thereof wherein the dashed line, A, B, Q, R1, R2, R3, R4, Y1, Z, and a are as defined herein, compositions comprising an effective amount of a Phosphorus-Substituted Quinoxaline-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Phosphorus-Substituted Quinoxaline-Type Piperidine Compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.